Carl J. Balibar

Statistics

Publications

Citations

3.4K

H-Index

Active since

2004

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Harvard University

United States Military Academy

Novartis (Switzerland)

Princeton University

Carl J. Balibar is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in biochemistry, natural sciences, and molecular biology.

ORCID

Top concepts

BiochemistryNatural SciencesMolecular BiologyBiosynthesisMicrobiologyChemical BiologyMedicineClinical MicrobiologyBacteriologyDrug Resistance

Publications per year

2004–2024

Publications

Minimum Information about a Biosynthetic Gene cluster

Marnix H. Medema, Renzo Kottmann, Pelin Yilmaz et al. · Nature Chemical Biology · 2015 · 869 citations · Full text

Selective small-molecule inhibition of an RNA structural element

John A. Howe, Hao Wang, Thierry Fischmann et al. · Nature · 2015 · 411 citations

Natural Sciences, Rna Structure Prediction, Selective Small-molecule Inhibition +3

Disruption of a Nonribosomal Peptide Synthetase in <i>Aspergillus fumigatus</i> Eliminates Gliotoxin Production

Robert A. Cramer, Michael P. Gamcsik, Rhea M. Brooking et al. · Eukaryotic Cell · 2006 · 212 citations · Full text

A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier

Elizabeth M. Hart, Angela M. Mitchell, Anna Konovalova et al. · Proceedings of the National Academy of Sciences · 2019 · 188 citations · Full text

In Vitro Biosynthesis of Violacein from <scp>l</scp>-Tryptophan by the Enzymes VioA−E from <i>Chromobacterium violaceum</i>

Carl J. Balibar, Christopher T. Walsh · Biochemistry · 2006 · 173 citations

Engineering, Molecular Biology, Escherichia Coli +17

1–5 of 30